The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Clinical translation of angiogenesis inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Self-citationTumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Self-citationVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Self-citationO'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Self-citationHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Self-citationEvidence for Circulating Bone Marrow-Derived Endothelial Cells
Shi, Q., Rafii, S., Wu, M. H.-D., Wijelath, E. S., Yu, C., Ishida, A., Fujita, Y., Kothari, S., Mohle, R., Sauvage, L. R., et al. (1998) · Blood · doi:10.1182/blood.v92.2.362 · Cited by 1,695
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Self-citationBrowder, T. D., Butterfield, C., Kräling, B. M., Shi, B., Marshall, B., OʼReilly, M., & Folkman, J. (2000) · PubMed · Cited by 1,543
Self-citationControl of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Self-citationRegulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Klement, G., Baruchel, S., Rak, J., Man, S., Clark, K., Hicklin, D. J., Bohlen, P., & Kerbel, R. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8829 · Cited by 1,168
Self-citationInterferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy
Ezekowitz, R. A. B., Mulliken, J. B., & Folkman, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262203 · Cited by 1,071
Self-citationTumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
(1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.301 · Cited by 981
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Hari, D. M., Kufe, D. W., et al. (1999) · PubMed · Cited by 947
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice
Hanahan, D., Bergers, G., & Bergsland, E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9872 · Cited by 865
Petit, A. M. V., Rak, J. W., Hung, M., Rockwell, P., Goldstein, N. I., FENDLY, B. M., & Kerbel, R. S. (1997) · Europe PMC (PubMed Central) · Cited by 836
Self-citationRelf, M., LeJeune, S., Scott, P. A. E., Fox, S. B., Smith, K. A., Leek, R., Moghaddam, A., Whitehouse, R. M., Bicknell, R., & Harris, A. L. (1997) · PubMed · Cited by 833
Hlatky, L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.883 · Cited by 787
Rak, J. W., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., & Kerbel, R. S. (1995) · PubMed · Cited by 762
Self-citationTumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2
Gimbrone, M. A., Cotran, R. S., Leapman, S. B., & Folkman, J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/52.2.413 · Cited by 758
Self-citationCombined effects of angiostatin and ionizing radiation in antitumour therapy
Mauceri, H. J., Hanna, N. N., Beckett, M. A., Gorski, D. H., Staba, M.-J., Stellato, K. A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., et al. (1998) · Nature · doi:10.1038/28412 · Cited by 668
Cellular markers that distinguish the phases of hemangioma during infancy and childhood.
Takahashi, K., Mulliken, J. B., Kozakewich, H. P., Rogers, R. A., Folkman, J., & Ezekowitz, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117241 · Cited by 648
Self-citationPerrotte, P., Matsumoto, T., Inoue, K., Kuniyasu, H., Eve, B. Y., Hicklin, D. J., Radinsky, R., & Dinney, C. P. (1999) · PubMed · Cited by 647
The microtubule-affecting drug paclitaxel has antiangiogenic activity.
Belotti, D., Vergani, V., Drudis, T., Borsotti, P., Pitelli, M. R., Viale, G., Giavazzi, R., & Taraboletti, G. (1996) · PubMed · Cited by 643
Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Fontanini, G., Cuccato, S., Placido, S. D., Bianco, A. R., & Tortora, G. (2001) · PubMed · Cited by 643
Sin, N., Meng, L., Wang, M. Q. W., Wen, J. J., Bornmann, W. G., & Crews, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6099 · Cited by 635
Bone marrow angiogenesis and progression in multiple myeloma
Vacca, A., Ribatti, D., Roncali, L., Ranieri, G., Serio, G., Silvestris, F., & Dammacco, F. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb08304.x · Cited by 630
Herceptin acts as an anti-angiogenic cocktail
Izumi, Y., Xu, L., di Tomaso, E., Fukumura, D., & Jain, R. K. (2002) · Nature · doi:10.1038/416279b · Cited by 623
(2000) · PubMed · Cited by 614
(2001) · PubMed · Cited by 605
Vacca, A., Ribatti, D., Presta, M., Minischetti, M., Iurlaro, M., Ria, R., Albini, A., Bussolino, F., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v93.9.3064 · Cited by 599
Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation
Mukhopadhyay, D., Tsiokas, L., Zhou, X.-M., Foster, D., Brugge, J. S., & Sukhatme, V. P. (1995) · Nature · doi:10.1038/375577a0 · Cited by 595
Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and Strategies
Jain, R. K. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.570 · Cited by 557
Srivastava, A., Laidler, P., Davies, R. P., Horgan, K. J., & Hughes, L. E. (1988) · PubMed Central · Cited by 528
Jiang, B.-H., Zheng, J. Z., Aoki, M., & Vogt, P. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040560897 · Cited by 528
Angiostatin binds ATP synthase on the surface of human endothelial cells
Moser, T. L., Stack, M. S., Asplin, I., Enghild, J. J., Højrup, P., Everitt, L., Hubchak, S., Schnaper, H. W., & Pizzo, S. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2811 · Cited by 526
Sidky, Y. A., & Borden, E. C. (1987) · PubMed · Cited by 494
Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth
Kamphaus, G. D., Colorado, P. C., Panka, D. J., Hopfer, H., Ramchandran, R., Torre, A., Maeshima, Y., Mier, J. W., Sukhatme, V. P., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1209 · Cited by 475
Secreted cathepsin L generates endostatin from collagen XVIII
Felbor, U. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1187 · Cited by 469
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
Arbiser, J. L., Moses, M. A., Fernandez, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D., Brownlee, M., Flynn, E., Parangi, S., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.861 · Cited by 469
Self-citationReversible Activation of c-Myc in Skin
Pelengaris, S., Littlewood, T., Khan, M., Elia, G., & Evan, G. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80350-0 · Cited by 468
Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., & Folkman, J. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.356 · Cited by 464
Self-citationKerbel, R. S. (1991) · BioEssays · doi:10.1002/bies.950130106 · Cited by 441
Self-citationSingh, R. K., Gutman, M., Bucana, C. D., Sanchez, R., Llansa, N., & Fidler, I. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4562 · Cited by 440
Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis
Maeshima, Y., Sudhakar, A., Lively, J. C., Ueki, K., Kharbanda, S., Kahn, C. R., Sonenberg, N., Hynes, R. O., & Kalluri, R. (2002) · Science · doi:10.1126/science.1065298 · Cited by 438
Antiangiogenic Activity of the Cleaved Conformation of the Serpin Antithrombin
O'Reilly, M. S., Pirie-Shepherd, S., Lane, W. S., & Folkman, J. (1999) · Science · doi:10.1126/science.285.5435.1926 · Cited by 432
Self-citationAnti-angiogenic cues from vascular basement membrane collagen.
Colorado, P. C., Torre, A., Kamphaus, G. D., Maeshima, Y., Hopfer, H., Takahashi, K., Volk, R., Zamborsky, E. D., Herman, S., Sarkar, P. K., et al. (2000) · PubMed · Cited by 426
Griffith, E. C., Su, Z., Turk, B. E., Chen, S., Chang, Y.-H., Wu, Z., Biemann, K., & Liu, J. O. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90198-8 · Cited by 421
Tumor Angiogenesis: A Quantitative Method for Histologic Grading 2
(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/48.2.347 · Cited by 414
Troyanovsky, B., Levchenko, T., Månsson, G., Matvijenko, O., & Holmgren, L. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1247 · Cited by 383
Gutheil, J. C., Campbell, T. N., Pierce, P. R., Watkins, J. D., Huse, W. D., Bodkin, D., & Cheresh, D. A. (2000) · PubMed · Cited by 369
Continuous release of endostatin from microencapsulated engineered cells for tumor therapy
Joki, T., Machluf, M., Atala, A., Zhu, J., Seyfried, N. T., Dunn, I. F., Abe, T., Carroll, R. S., & Black, P. M. (2001) · Nature Biotechnology · doi:10.1038/83481 · Cited by 365
Involvement of platelets in tumour angiogenesis?
Pinedo, H., Verheul, H., D'Amato, R., & Folkman, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05095-8 · Cited by 358
Self-citationc-fos is required for malignant progression of skin tumors
Saez, E., Rutberg, S. E., Mueller, E., Oppenheim, H., Smoluk, J., Yuspa, S. H., & Spiegelman, B. M. (1995) · Cell · doi:10.1016/0092-8674(95)90469-7 · Cited by 346
Meitar, D., Crawford, S. E., Rademaker, A. W., & Cohn, S. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.405 · Cited by 342
Slaton, J. W., Perrotte, P., Inoue, K., Dinney, C. P., & Fidler, I. J. (1999) · PubMed · Cited by 337
Heaney, A. P., Horwitz, G. A., Wang, Z., Singson, R., & Melmed, S. (1999) · Nature Medicine · doi:10.1038/15275 · Cited by 337
Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., & Marmé, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25915 · Cited by 329
Inhibition of Cell Motility by Interferon
Brouty-Boyé, D., & Zetter, B. R. (1980) · Science · doi:10.1126/science.6154315 · Cited by 326
The generation of endostatin is mediated by elastase.
Wen, W. X., Moses, M. A., Wiederschain, D., Arbiser, J. L., & Folkman, J. (1999) · PubMed · Cited by 318
Self-citationProgress in cancer research and therapy
Frank, A. L. (1978) · Environmental Research · doi:10.1016/0013-9351(78)90093-2 · Cited by 309
Shima, D. T., Deutsch, U., & D'Amore, P. A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00831-s · Cited by 305
Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
Streit, M., Riccardi, L., Velasco, P., Brown, L. F., Hawighorst, T., Bornstein, P., & Detmar, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14888 · Cited by 302
Blezinger, P., Wang, J., Gondo, M., Quezada, A., Mehrens, D., French, M., Singhal, A., Sullivan, S., Rolland, A., Ralston, R., et al. (1999) · Nature Biotechnology · doi:10.1038/7895 · Cited by 299
Angiogenesis-dependent diseases
FOLKMAN, J. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90021-1 · Cited by 295
Self-citationLocal endostatin treatment of gliomas administered by microencapsulated producer cells
Read, T.-A., Sorensen, D. R., Mahesparan, R., Enger, P. Ø., Timpl, R., Olsen, B. R., Hjelstuen, M. H. B., Haraldseth, O., & Bjerkvig, R. (2001) · Nature Biotechnology · doi:10.1038/83471 · Cited by 293
Rak, J. W., Mitsuhashi, Y., Sheehan, C., Tamir, A., Viloria‐Petit, A., Filmus, J., Mansour, S. J., Ahn, N. G., & Kerbel, R. S. (2000) · PubMed · Cited by 288
Self-citationKisker, O., Becker, C. M., Prox, D., Fannon, M. W., D’Amato, R. J., Flynn, E. A., Fogler, W. E., Sim, B. K. L., Allred, E. N., Pirie-Shepherd, S. R., et al. (2001) · PubMed · Cited by 283
Self-citationKanthou, C., & Tozer, G. M. (2002) · Blood · doi:10.1182/blood.v99.6.2060 · Cited by 280
Dixelius, J., Larsson, H., Sasaki, T., Holmqvist, K., Lu, L., Engström, A., Timpl, R., Welsh, M., & Claesson-Welsh, L. (2000) · Blood · doi:10.1182/blood.v95.11.3403 · Cited by 271
Kuo, C. J., Farnebo, F., Yu, E. Y., Christofferson, R., Swearingen, R. A., Carter, R., von Recum, H. A., Yuan, J., Kamihara, J., Flynn, E., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081615298 · Cited by 271
Self-citationPhosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase
Lay, A. J., Jiang, X.-M., Kisker, O., Flynn, E., Underwood, A., Condron, R., & Hogg, P. J. (2000) · Nature · doi:10.1038/35048596 · Cited by 267
Zhang, L., Yu, D., Hu, M., Xiong, S., Lang, A., Ellis, L. M., & Pollock, R. E. (2000) · PubMed · Cited by 263
Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen, K. A., Moses, M. A., Beecken, W.-D. C., Khan, M. K., Folkman, J., & O’Reilly, M. S. (2001) · PubMed · Cited by 261
Self-citationAngiogenesis Research: Guidelines for Translation to Clinical Application
Browder, T., Palmblad, J., & Folkman, J. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616197 · Cited by 259
Self-citationRibatti, D., Vacca, A., Nico, B., Quondamatteo, F., Ria, R., Minischetti, M., Marzullo, A., Herken, R., Roncali, L., & Dammacco, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690070 · Cited by 247
Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2a
Kaban, L. B., Mulliken, J. B., Ezekowitz, R. A., Phil, D., Ebb, D., Smith, P. S., & Folkman, J. (1999) · Pediatrics · doi:10.1542/peds.103.6.1145 · Cited by 245
Self-citationConsequences of angiogenesis for tumor progression, metastasis and cancer therapy
Rak, J. W., St Croix, B. D., & Kerbel, R. S. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199502000-00001 · Cited by 243
Self-citationKerbel, R. S., Yu, J., Tran, J., Man, S., Viloria-Petit, A., Klement, G., Coomber, B. L., & Rak, J. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013172910858 · Cited by 237
Self-citationOncogenes as inducers of tumor angiogenesis
Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marm�, D., & Kerbel, R. S. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690598 · Cited by 235
Self-citationPotentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents
Teicher, B. A., Holden, S. A., Ara, G., Sotomayor, E. A., Huang, Z. D., Chen, Y., & Brem, H. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570624 · Cited by 231
Raje, N., & Anderson, K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412110 · Cited by 230
Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived Tumstatin
Maeshima, Y., Manfredi, M., Reimer, C., Holthaus, K. A., Hopfer, H., Chandamuri, B. R., Kharbanda, S., & Kalluri, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007764200 · Cited by 230
Oncogenes and Angiogenesis: Signaling Three-Dimensional Tumor Growth
Rak, J., Yu, J. L., Klement, G., & Kerbel, R. S. (2000) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2000.00012.x · Cited by 222
Self-citationZabrenetzky, V., Harris, C. C., Steeg, P. S., & Roberts, D. D. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590209 · Cited by 219
Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws
Kaban, L. B., Troulis, M. J., Ebb, D., August, M., Hornicek, F. J., & Dodson, T. B. (2002) · Journal of Oral and Maxillofacial Surgery · doi:10.1053/joms.2002.34975 · Cited by 219
Mendel, D. B., Schreck, R., West, D. C., Li, G., Strawn, L. M., Tanciongco, S. S., Vasile, S., Shawver, L. K., & Cherrington, J. M. (2000) · PubMed · Cited by 215
Infant Heart Transplantation at Stanford: Growth and Neurodevelopmental Outcome
Fleisher, B. E., Baum, D., Brudos, G., Burge, M., Carson, E., Constantinou, J., Duckworth, J., Gamberg, P., Klein, P., Luikart, H., et al. (2002) · Pediatrics · doi:10.1542/peds.109.1.1 · Cited by 212
Microvascular Injury in Pathogenesis of Interferon-Induced Necrosis of Subcutaneous Tumors in Mice
Dvorak, H. F., & Gresser, I. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.7.497 · Cited by 192
(1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9 · Cited by 185
López-Ocejo, O., Viloria-Petit, A., Bequet-Romero, M., Mukhopadhyay, D., Rak, J., & Kerbel, R. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203817 · Cited by 183
Self-citationThalidomide in the Treatment of Relapsed Multiple Myeloma
Rajkumar, S. V., Fonseca, R., Dispenzieri, A., Lacy, M. Q., Lust, J. A., Witzig, T. E., Kyle, R. A., Gertz, M. A., & Greipp, P. R. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.9.897 · Cited by 183
Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells
Brunner, G., Nguyen, H., Gabrilove, J., Rifkin, D., & Wilson, E. (1993) · Blood · doi:10.1182/blood.v81.3.631.631 · Cited by 182
Establishing a Link between Oncogenes and Tumor Angiogenesis
Kerbel, R. S., Viloria‐Petit, A., Okada, F., & Rak, J. W. (1998) · Molecular Medicine · doi:10.1007/bf03401737 · Cited by 168
Self-citationThe Development of Human Gene Therapy
Nabel, E. G. (1999) · Nature Medicine · doi:10.1038/10443 · Cited by 163
Successful Treatment of an Angiogenic Disease
Folkman, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201811 · Cited by 162
Self-citationMonestiroli, S., Mancuso, P., Burlini, A., Pruneri, G., Dell’Agnola, C., Gobbi, A., Martinelli, G., & Bertolini, F. (2001) · PubMed · Cited by 159
Takahashi, N., Haba, A., Matsuno, F., & Seon, B. K. (2001) · PubMed · Cited by 150
Udagawa, T., Fernández, A., Achilles, E., Folkman, J., & D’Amato, R. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0813com · Cited by 150
Self-citationHeterogeneous Vascular Dependence of Tumor Cell Populations
Yu, J., Rak, J. W., Carmeliet, P., Nagy, A., Kerbel, R. S., & Coomber, B. L. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64083-7 · Cited by 150
Self-citationBielenberg, D. R., Bucana, C. D., Sanchez, R. R., Mulliken, J. B., Folkman, J., & Fidler, I. J. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.3.401 · Cited by 147
Self-citationRajkumar, S. V., Fonseca, R., Witzig, T. E., Gertz, M. A., & Greipp, P. (1999) · Leukemia · doi:10.1038/sj.leu.2401336 · Cited by 147
McGregor, L. M., McCune, B. K., Graff, J. R., McDowell, P. R., Romans, K. E., Yancopoulos, G. D., Ball, D. W., Baylin, S. B., & Nelkin, B. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4540 · Cited by 146
THE DEVELOPMENT OF HUMAN GENE THERAPY
Friedmann, T. (1999) · Cited by 138
Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge
Gorelik, E. (1983) · Advances in cancer research · doi:10.1016/s0065-230x(08)61033-7 · Cited by 135
Bauditz, J., Wedel, S., & Lochs, H. (2002) · Gut · doi:10.1136/gut.50.2.196 · Cited by 132
Dezube, B. J., Roenn, J. H. V., Holden‐Wiltse, J., Cheung, T., Remick, S. C., Cooley, T. P., Moore, J., Sommadossi, J., Shriver, S., Suckow, C., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1444 · Cited by 129
Tille, J., Wood, J. M., Mandriota, S. J., Schnell, C., Ferrari, S. M., Mestan, J., Zhu, Z., Witte, L., & Pepper, M. S. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29231-4 · Cited by 127
Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470
Kudelka, A. P., Verschraegen, C. F., & Loyer, E. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804023381412 · Cited by 126
Antiangiogenic Agents in Cancer Therapy
Teicher, B. A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-453-5 · Cited by 124
Multi-Institutional Study of the Angiogenesis Inhibitor TNP-470 in Metastatic Renal Carcinoma
Stadler, W. M., Kuzel, T. M., Shapiro, C. M., Sosman, J. A., Clark, J. I., & Vogelzang, N. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2541 · Cited by 123
Auvinen, M. I., Laine, A., Paasinen-Sohns, A., Kangas, A., Kangas, L., Saksela, O., Andersson, L. C., & Hölttä, E. (1997) · PubMed · Cited by 121
Scappaticci, F. A., Smith, R., Pathak, A., Schloss, D. J., Lum, B. L., Cao, Y., Johnson, F. L., Engleman, E. G., & Nolan, G. P. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0243 · Cited by 114
What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors?
Rak, J. W., Yu, J., Kerbel, R. S., & Coomber, B. L. (2002) · PubMed · Cited by 113
Self-citationAngiogenesis in B Cell Lymphoproliferative Diseases. Biological and Clinical Studies
Vacca, A., Ribatti, D., Roncali, L., & Dammacco, F. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509054750 · Cited by 102
Achilles, E. G., Fernandez, A., Allred, E. N., Kisker, O., Udagawa, T., Beecken, W.-D., Flynn, E. A., & Folkman, J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1075 · Cited by 100
Self-citationAngiogenic Potential of Prostate Carcinoma Cells Overexpressing bcl-2
Fernandez, A., Udagawa, T., Meyer‐Schwesinger, C., Beecken, W.-D., Achilles-Gerte, E., McDonnell, T. J., & D’Amato, R. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.208 · Cited by 99
Bertolini, F., Mingrone, W. B., Alietti, A., Ferrucci, P. F., Cocorocchio, E., Peccatori, F. A., Cineri, S., Mancuso, P., Corsini, C. A., Burlini, A., et al. (2001) · Annals of Oncology · doi:10.1023/a:1011141009812 · Cited by 95
GROWTH OF A LOCAL TUMOR EXERTS A SPECIFIC INHIBITORY EFFECT ON PROGRESSION OF LUNG METASTASES
Gorelik, E., Segal, S., & Feldman, M. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210512 · Cited by 94
Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors.
Perletti, G., Concari, P., Giardini, R., Marras, E., Piccinini, F., Folkman, J., & Chen, L. (2000) · PubMed · Cited by 93
Self-citationAntiangiogenic agents can increase tumor oxygenation and response to radiation therapy
Teicher, B. A., Dupuis, N. P., Kusomoto, T., Robinson, M. F., Liu, F., Menon, K., & Coleman, C. N. (1994) · Radiation Oncology Investigations · doi:10.1002/roi.2970020604 · Cited by 93
Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (Review)
Blagosklonny, M. V. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.2.257 · Cited by 92
Effect of Antiangiogenic Therapy on Slowly Growing, Poorly Vascularized Tumors in Mice
Beecken, W.-D., Fernandez, A., Joussen, A. M., Achilles, E. G., Flynn, E., Lo, K.-M., Gillies, S. D., Javaherian, K., Folkman, J., & Shing, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.5.382 · Cited by 89
Self-citationGeneration of multiple angiogenesis inhibitors by human pancreatic cancer.
Kisker, O., Onizuka, S., Banyard, J., Komiyama, T., Becker, C. M., Achilles, E. G., Barnés, C. M., O’Reilly, M. S., Folkman, J., & Pirie-Shepherd, S. R. (2001) · PubMed · Cited by 86
Self-citationIndraccolo, S., Gola, E., Rosato, A., Minuzzo, S. A., Habeler, W., Tisato, V., Roni, V., Esposito, G., Morini, M., Albini, A., et al. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301703 · Cited by 83
Marler, J. J., Rubin, J. B., Trede, N. S., Connors, S. L., Grier, H. E., Upton, J. M., Mulliken, J. B., & Folkman, J. (2002) · PEDIATRICS · doi:10.1542/peds.109.2.e37 · Cited by 78
Self-citationDing, I., Sun, J., Fenton, B. M., Liu, W. M., Kimsely, P., Okunieff, P. G., & Min, W. (2001) · PubMed · Cited by 77
Verheul, H. M. W., Panigrahy, D., Yuan, J., & D’Amato, R. J. (1998) · British Journal of Cancer · doi:10.1038/sj.bjc.6690020 · Cited by 73
Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma
D’Amato, R. J., Lentzsch, S., Anderson, K. C., & Rogers, M. S. (2001) · Seminars in Oncology · doi:10.1053/sonc.2001.28601 · Cited by 72
Butyrate in the treatment of sickle cell disease and β-thalassemia
Faller, D. V., & Perrine, S. P. (1995) · Current Opinion in Hematology · doi:10.1097/00062752-199502020-00002 · Cited by 62
Fotsis, T., Breit, S., Lutz, W., Rössler, J. K., Hatzi, E. G., Schwab, M., & Schweigerer, L. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00575.x · Cited by 58
Eisterer, W., Jiang, X., Bachelot, T., Pawliuk, R., Abramovich, C., Leboulch, P., Hogge, D. E., & Eaves, C. J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0573 · Cited by 57
Settles, B., Stevenson, A., Wilson, K., Mack, C., Ezell, T., Davis, M. F., & Taylor, L. D. (2001) · PubMed · Cited by 55
Continuous Intravascular Secretion of Endostatin in Mice from Transduced Hematopoietic Stem Cells
Pawliuk, R., Bachelot, T., Zurkiya, O., Eriksson, A., Cao, Y., & Leboulch, P. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0572 · Cited by 54
Chamberlain, M. C. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550170036012 · Cited by 50
Shi, W., Teschendorf, C., Muzyczka, N., & Siemann, D. W. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700463 · Cited by 50
Feldman, A. L., Alexander, H. R., Hewitt, S. M., Lorang, D., Thiruvathukal, C. E., Turner, E. M., & Libutti, S. K. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.1014 · Cited by 49
Transformation by v-src causes transient induction followed by repression of mouse thrombospondin-1.
Slack, J., & BORNSTEIN, P. K. (1994) · PubMed · Cited by 48
Reimer, C., Agata, N., Tammam, J. G., Bamberg, M., Dickerson, W. M., Kamphaus, G. D., Rook, S. L., Milhollen, M. A., Fram, R. J., Kalluri, R., et al. (2002) · PubMed · Cited by 47
Zomas, A., Anagnostopoulos, N., & Dimopoulos, M. A. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702444 · Cited by 47
Downmodulation of bFGF-binding protein expression following restoration of p53 function
Sherif, Z. A., Nakai, S., Pirollo, K. F., Rait, A. S., & Chang, E. H. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700361 · Cited by 45
Measurement of the grade of vascularisation in histological tumour tissue sections
Mlynek, M. ‐., van Beunigen, D., Leder, L.-D., & Streffer, C. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.282 · Cited by 45
Accomplishments in cancer research
Reizenstein, P. (1987) · Medical Oncology and Tumor Pharmacotherapy · doi:10.1007/bf02934951 · Cited by 43
Buanec, H. L., D'Anna, R., Lachgar, A., Zagury, J., Bernard, J., Ittelé, D., d’Alessio, P., Hallez, S., Giannouli, C., Burny, A., et al. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80122-x · Cited by 41
SU6668, a multitargeted angiogenesis inhibitor.
Hoekman, K. (2002) · PubMed · Cited by 37
Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor
Soffer, S. Z., Kim, E. S., Moore, J. T., Huang, J., Yokoi, A., Manley, C. A., O’Toole, K., Middlesworth, W., Stolar, C. J. H., Yamashiro, D. J., et al. (2001) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2001.28823 · Cited by 36
Fu, X., Roberts, W. G., Nobile, V., Shapiro, R., & Kamps, M. P. (1999) · Growth Factors · doi:10.3109/08977199909103521 · Cited by 33
Calvo, A., Feldman, A. L., Libutti, S. K., & Green, J. E. (2002) · PubMed · Cited by 32
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
(1995) · PubMed
(2001) · PubMed
Cited by
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Metadata
- Authors
- Kerbel, R., & Folkman, J.
- Venue
- Nature Reviews Cancer
- Published
- 2002-10
- Volume
- 2
- Issue
- 10
- Pages
- 727-739
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2064360454
- Cited by
- 1,517
- References
- 163
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.